Related Experiment Video
Updated: Mar 11, 2026

11:58
Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
8.8K
Discovery of RNA Binding Small Molecules Using Small Molecule Microarrays
Colleen M Connelly1, Fardokht A Abulwerdi1, John S Schneekloth2
1Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, 21702, USA.
Methods in Molecular Biology (Clifton, N.J.)
|November 23, 2016
Summary
New small molecule microarrays (SMMs) enable rapid identification of compounds that bind to specific RNA molecules. This approach advances RNA-targeted drug discovery for various diseases.
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Biology
Background:
- Pharmacological targeting of RNA offers new therapeutic avenues for diseases.
- Small molecule-RNA interactions are crucial for modulating RNA function.
- Developing efficient screening methods is key to identifying RNA-binding small molecules.
Purpose of the Study:
- To present a general method for preparing and utilizing small molecule microarrays (SMMs).
- To enable the rapid identification of small molecules that selectively bind to a target RNA.
- To facilitate the exploration of RNA-driven biology and disease states through small molecule modulation.
Main Methods:
- Generation of small molecule microarrays (SMMs) by spatially arraying and covalently linking small molecules to a glass surface.
- Incubation of SMMs with fluorescently labeled RNA to detect binding interactions.
- Slide imaging for the detection and analysis of RNA-small molecule binding events.
Main Results:
- Demonstrated a generalizable method for SMM preparation and application.
- Enabled rapid screening of numerous small molecules against diverse RNA targets.
- Provided insights into the binding and selectivity of identified RNA-small molecule interactions.
Conclusions:
- Small molecule microarrays (SMMs) provide a powerful platform for identifying RNA-binding small molecules.
- This method accelerates the discovery of potential therapeutics for RNA-related diseases.
- The approach supports the screening of various RNA types, expanding drug discovery opportunities.
More Related Videos
Related Concept Videos
DNA Microarrays
21.7K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.7K
RNA-seq
12.3K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.3K
Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K
RNA Interference
7.8K
7.8K
siRNA - Small Interfering RNAs
18.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K

